Oncology leads the way in drug development across all therapeutic areas
PhRMA released its "Pharmaceutical Pipeline Report" today. Not too surprising to see all the activity in oncology. But almost a third of the research across all phases is targeting oncology...from CAR-T therapies to PD1 combinations to gene therapy. Check out the full report at link below.